Listing 1 - 10 of 49 | << page >> |
Sort by
|
Choose an application
Choose an application
L'objet de cet ouvrage est d'apporter aux professionnels de la gériatrie les repères théoriques et cliniques nécessaires au travail avec le couple formé par le patient âgé dépendant et l'aidant qui l'accompagne. Sous le mode de l'étude de cas, des situations cliniques représentatives des étapes de la relation de dépendance sont chaque fois discutées selon deux grands axes : l'analyse des interactions du couple aidé-aidé et les perspectives de son accompagnement en fonction des besoins de chacun de ses protagonistes, depuis le maintien à domicile jusqu'à l'entrée en institution et au-delà, à travers les relations de l'équipe soignante avec les familles.
Choose an application
Choose an application
Cancer, dementia, and cardiovascular disease are responsible for almost two million deaths each year in the United States alone and represent the largest immediate threat to humanity. Over the last century, we have made spectacular advances that have transformed our society - splitting the atom, space travel, telecommunications, and the Internet - but with medical research focused mostly on science for the sake of science, it has yielded precious few cures. A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease represents a "first of its kind" effort to address both the reasons for this and to posit solutions to fix our broken system, in an effort to finally end this cure crisis. Dr. Marangos draws on 45 years of experience in every aspect of the biomedical R&D field, from basic drug discovery research at the NIH to the co-founding of five drug companies. He has published 252 research papers and edited four books on drug discovery, is co-inventor on 14 patents, and founded "The Journal of Molecular Neuroscience". He argues that from a development perspective, the regulatory, patent, and legal hurdles that force industry to pursue so-called "me-too" drugs rather than cures for terminal diseases must be re-thought. Leadership accountability, strategy, focus, and urgency need to be re-evaluated, and major reforms to the NIH, FDA, and patent codes are proposed.to remedy these impediments to cures. Written for anyone frustrated with the seemingly endless threat of terminal disease, this book seeks to inform, energize, and provide the rationale for the public and industry stakeholders, as well as clinicians and researchers, to resurrect the physician-patient relationship and demand that we get serious about ridding society of this scourge on humanity.--
Choose an application
Choose an application
Cancer, dementia, and cardiovascular disease are responsible for almost two million deaths each year in the United States alone and represent the largest immediate threat to humanity. Over the last century, we have made spectacular advances that have transformed our society - splitting the atom, space travel, telecommunications, and the Internet - but with medical research focused mostly on science for the sake of science, it has yielded precious few cures. A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease represents a "first of its kind" effort to address both the reasons for this and to posit solutions to fix our broken system, in an effort to finally end this cure crisis. Dr. Marangos draws on 45 years of experience in every aspect of the biomedical R&D field, from basic drug discovery research at the NIH to the co-founding of five drug companies. He has published 252 research papers and edited four books on drug discovery, is co-inventor on 14 patents, and founded "The Journal of Molecular Neuroscience". He argues that from a development perspective, the regulatory, patent, and legal hurdles that force industry to pursue so-called "me-too" drugs rather than cures for terminal diseases must be re-thought. Leadership accountability, strategy, focus, and urgency need to be re-evaluated, and major reforms to the NIH, FDA, and patent codes are proposed.to remedy these impediments to cures. Written for anyone frustrated with the seemingly endless threat of terminal disease, this book seeks to inform, energize, and provide the rationale for the public and industry stakeholders, as well as clinicians and researchers, to resurrect the physician-patient relationship and demand that we get serious about ridding society of this scourge on humanity.--
Choose an application
Choose an application
Alzheimer's disease --- Caregivers --- Alzheimer's disease --- Patients --- Care
Choose an application
Alzheimer décrit de l'intérieurv ... Annie-Claude Nakau est atteinte du syndrome de Benson, pathologie proche de l'Alzheimer. Auteure et narratrice, elle raconte comment elle perd la vue à une vitesse vertigineuse et se trouve destituée progressivement de ses capacités intellectuelles et physiques. Ce témoignage, tragique mais beau, et universel, raconte l'émiettement du monde, la perte de repères, la détresse de l'entourage des malades atteints d'Alzheimer. Voilà le récit de la vie d'une femme pour qui lire, écrire ou encore conduire deviennent autant de murs infranchissables, et qui se voit peu à peu mise au ban de la société par la faute d'une maladie sur laquelle les chercheurs peinent encore à se prononcer. Slatkine & Cie a saisi l'opportunité de donner la parole à un auteur qui, par sa propre expérience de la maladie et son introspection, nous fait part d'un témoignage inédit sur la maladie d'Alzheimer. EXTRAIT Il se passe aussi quelque chose de nouveau, que je dois prendre au sérieux. Je viens de me réveiller dans cette chambre impersonnelle, assise, mais le suis-je vraiment ? Dans l'obscurité, je distingue très clairement les silhouettes de plusieurs personnes autour de mon lit. La surprise me tire de mon demi-sommeil. Il n'y a pas d'agitation dans la pièce. Simplement toutes ces présences paisibles, dont je ne sais ni pourquoi ni comment elles sont entrées dans ma chambre. Curieusement je n'ai pas peur. Ces présences ne sont pas malveillantes. Sont-elles seulement incongrues ? J'aimerais simplement comprendre qui elles sont. CE QU'EN PENSE LA CRITIQUE Un ouvrage fort, admirablement bien écrit, indispensable. - Raphaëlle Murignieux, Âge village.
Alzheimer's disease. --- Alzheimer's disease --- PatientsxDay care.
Choose an application
The End of Alzheimer's: The Brain and Beyond, Second Edition is the first comprehensive overview on the molecular basis of Alzheimer's outside of the brain, merging the most recent findings within the field into a single book. It aims to educate the reader on the many overlooked aspects of Alzheimer's disease that occur outside the brain. This book uniquely provides step-by-step, peer-reviewed evidence that the current research model may be misguided and that a new and emerging model is more accurate. It carefully outlines the molecular research in Alzheimer's outside the brain and argues that a more thorough, whole-body diagnosis will provide better answers about its causes and lead to new treatments. It is beneficial to researchers who need to be apprised of the emerging science on the causes of Alzheimer's, and will hopefully redirect many into new avenues of cellular research and discovery.--
Alzheimer's disease. --- Alzheimer's disease --- Diagnosis. --- Prevention.
Listing 1 - 10 of 49 | << page >> |
Sort by
|